All In Biotech

Drug Trial Radar · NCT06858397

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

An Open Label, Dose Range, Proof-of-Concept Study to Assess the Safety and Efficacy of HM15421/GC1134A in Patients With Fabry Disease

Last checked: Nov 19, 2026Latest source record: Nov 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

18

Planned (sponsor's estimate)

Start

May 14, 2025

Primary completion

Aug 30, 2028

Study completion Aug 30, 2028

Sponsor

Lead sponsor
GC Biopharma CorpIndustry
Sponsor type
Industry
Collaborators
Hanmi Pharmaceutical Company Limited
First posted
Mar 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD.

Conditions

  • Fabry Disesase

Interventions

  • HM15421/GC1134ADrug

    SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidences and characteristics of adverse eventsTime frame: Up to 48 weeks

Locations

10 sites in 3 countries. Site status is shown where the registry gives one.

  • David Geffen School of Medicine UCLA, UCLA Health

    Los Angeles, California · Recruiting

  • University of Kansas School of Medicine

    Kansas City, Kansas · Recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • Children's Hospital Medical Center

    Cincinnati, Ohio · Recruiting

  • University of Pittsburgh Medical Center Children's Hoispital of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

  • Lysosomal and Rare Disorders Research and Treatment Center

    Fairfax, Virginia · Recruiting

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina · Recruiting

  • Centro Medico IPAM

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Yonsei University, College of Medicine

    Seoul, South Korea · Recruiting

  • Pusan National University Children's Hospital in Yangsan

    Yangsan, Gyeongsangnam-do, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.